Submission log

A tool is in scope when a model makes a judgment or estimate, the output bears on a person's body, health data, care, coverage, or a health decision, and there is a nameable route to what a patient understands, decides, or can act on. Invisible AI used on patients counts. Commercial status, regulatory status, and clinical setting are findings inside a profile, not entry requirements.

A decision here is a judgment about scope, not a finding about the tool. An out-of-scope entry means the tool falls outside what HugoScore reviews. It says nothing about whether the tool is good, safe, or worth using. Submitter names, email addresses, and note text are never published.

• CareClinic Health Tracker + connected AI assistant Reviewed

  The connected AI host interprets authorized health records; the deterministic tracker alone is not the reviewed AI deployment. Published as a potentially agency-expanding, unscored AI-assisted draft.

  Received Sep 27, 2026 · Affiliation not disclosed · See the profile

• Anistratenco Health Assistant Reviewed

  Consumer AI interpretation of health information creates a patient-impact pathway. Published as a potentially agency-expanding, unscored AI-assisted draft.

  Received Sep 27, 2026 · Submitted by the vendor · See the profile

• aidoctorscan Reviewed

  AI interpretation and suggested urgency for visible symptoms can affect care-seeking. Profiled as a Mixed, unscored AI-assisted draft.

  Received Sep 17, 2026 · Submitted by the vendor · See the profile

• Ari (Citizen Health / RARE-X partnership) Reviewed

  AI assistance with records, care navigation and coverage appeals provides a direct patient-impact pathway. Profiled as an unscored AI-assisted draft with a Mixed agency posture.

  Received Sep 15, 2026 · Affiliation not disclosed · See the profile

• Protein Buddy In scope, not queued

  Clears the scope test through one narrow pathway: the onboarding quiz raises the daily protein target for people taking GLP-1 medications, and the vendor directs users to confirm the target with their prescriber. Better handled inside a category brief on GLP-1 adjacent consumer AI than as a standalone profile.

  Revised Aug 24, 2026: Submitted a second time the same day. The submitter confirmed they are part of the Protein Buddy team, which matches how the entry was already logged, and argued for a broader patient impact pathway covering any user choosing a meal. The decision is unchanged. The second submission restated the case in the vocabulary of the scope test but added no new facts about the tool, and the GLP-1 pathway remains the specific route that clears the gates.

  Received Aug 24, 2026 · Reason code: covered-by-category · Submitted by the vendor

• Noah AI Reviewed

  Professional evidence tool reachable by patients, with the largest patient effects flowing through drug-program, launch, coverage, and investment decisions. Profiled as an AI-assisted draft at 55 on the agency axis.

  Received Aug 12, 2026 · Affiliation not disclosed · See the profile

• BastionGPT Reviewed

  Clinician-facing AI whose outputs shape patient documents and clinical reasoning inside organizations that patients do not choose. Profiled as an AI-assisted draft at 16 on the agency axis.

  Received Jul 27, 2026 · Affiliation not disclosed · See the profile